424 related articles for article (PubMed ID: 23944608)
1. β- and α-Thalassemia intermedia in Basra, Southern Iraq.
Abdulwahid DA; Hassan MK
Hemoglobin; 2013; 37(6):553-63. PubMed ID: 23944608
[TBL] [Abstract][Full Text] [Related]
2. Beta-Thalassemia Intermedia: A Single Thalassemia Center Experience from Northeastern Iraq.
Amin SS; Jalal SD; Ali KM; Mohammed AI; Rasool LK; Osman TJ
Biomed Res Int; 2020; 2020():2807120. PubMed ID: 32190657
[TBL] [Abstract][Full Text] [Related]
3. The correlation of α-globin gene mutations and the XmnI polymorphism with clinical severity of Hb E/β-thalassemia.
Charoenkwan P; Teerachaimahit P; Sanguansermsri T
Hemoglobin; 2014; 38(5):335-8. PubMed ID: 25238043
[TBL] [Abstract][Full Text] [Related]
4. Interaction of an α-Globin Gene Triplication with β-Globin Gene Mutations in Iranian Patients with β-Thalassemia Intermedia.
Farashi S; Bayat N; Faramarzi Garous N; Ashki M; Montajabi Niat M; Vakili S; Imanian H; Zeinali S; Najmabadi H; Azarkeivan A
Hemoglobin; 2015; 39(3):201-6. PubMed ID: 26084319
[TBL] [Abstract][Full Text] [Related]
5. [A rare thalassemia intermedia case caused by co-existence of Hb H disease (--(SEA)/-alpha(4.2)) and beta-thalassemia major (beta (CD17A)>T/beta (IVS2-654C)>T): implications for prenatal diagnosis].
Li Q; Li LY; Mo QH
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jan; 28(1):16-9. PubMed ID: 18227017
[TBL] [Abstract][Full Text] [Related]
6. Genetic Modifiers in β-Thalassemia Intermedia: A Study on 102 Iraqi Arab Patients.
Al-Allawi NA; Puehringer H; Raheem RA; Oberkanins C
Genet Test Mol Biomarkers; 2015 May; 19(5):242-7. PubMed ID: 25751242
[TBL] [Abstract][Full Text] [Related]
7. Extended molecular spectrum of beta- and alpha-thalassemia in Oman.
Hassan SM; Hamza N; Jaffer Al-Lawatiya F; Jaffer Mohammed A; Harteveld CL; Rajab A; Giordano PC
Hemoglobin; 2010 Jan; 34(2):127-34. PubMed ID: 20353347
[TBL] [Abstract][Full Text] [Related]
8. [Current management of thalassemia intermedia].
Thuret I
Transfus Clin Biol; 2014 Nov; 21(4-5):143-9. PubMed ID: 25282488
[TBL] [Abstract][Full Text] [Related]
9. Molecular Basis of β-Thalassemia Intermedia in Erbil Province of Iraqi Kurdistan.
Shamoon RP; Al-Allawi NA; Cappellini MD; Di Pierro E; Brancaleoni V; Granata F
Hemoglobin; 2015; 39(3):178-83. PubMed ID: 25902180
[TBL] [Abstract][Full Text] [Related]
10. Genetic determinants of β-thalassemia intermedia in Pakistan.
Khan J; Ahmad N; Siraj S; Hoti N
Hemoglobin; 2015; 39(2):95-101. PubMed ID: 25707679
[TBL] [Abstract][Full Text] [Related]
11. Multicenter study of the molecular basis of thalassemia intermedia in different ethnic populations.
Verma IC; Kleanthous M; Saxena R; Fucharoen S; Winichagoon P; Raizuddin S; Khan SN; Akbari MT; Izadyar M; Kotea N; Old JM; Ioannou PA; Khan B
Hemoglobin; 2007; 31(4):439-52. PubMed ID: 17994378
[TBL] [Abstract][Full Text] [Related]
12. Genotype-phenotype correlation related to lipid profile in beta-thalassemia major and intermedia in southern Iran.
Bordbar M; Haghpanah S; Afrasiabi A; Dehbozorgian J; Karimi M
J Clin Lipidol; 2012; 6(2):108-13. PubMed ID: 22385543
[TBL] [Abstract][Full Text] [Related]
13. Alpha and beta thalassemia.
Muncie HL; Campbell J
Am Fam Physician; 2009 Aug; 80(4):339-44. PubMed ID: 19678601
[TBL] [Abstract][Full Text] [Related]
14. Clinical and Molecular Characteristics of Non-Transfusion-Dependent Thalassemia in Kuwait.
Adekile AD; Azab AF; Al-Sharida SI; Al-Nafisi BA; Akbulut N; Marouf RA; Mustafa NY
Hemoglobin; 2015; 39(5):320-6. PubMed ID: 26076396
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis of thalassemia intermedia in Iran.
Akbari MT; Izadi P; Izadyar M; Kyriacou K; Kleanthous M
Hemoglobin; 2008; 32(5):462-70. PubMed ID: 18932071
[TBL] [Abstract][Full Text] [Related]
16. Hb H disease with various β hemoglobinopathies: molecular, hematological and diagnostic aspects.
Fucharoen S; Fucharoen G
Hemoglobin; 2012; 36(1):18-24. PubMed ID: 22145566
[TBL] [Abstract][Full Text] [Related]
17. Insight onto the pathophysiology and clinical complications of thalassemia intermedia.
Cappellini MD; Musallam KM; Taher AT
Hemoglobin; 2009; 33 Suppl 1():S145-59. PubMed ID: 20001620
[TBL] [Abstract][Full Text] [Related]
18. Response to hydroxycarbamide in pediatric β-thalassemia intermedia: 8 years' follow-up in Egypt.
El-Beshlawy A; El-Ghamrawy M; EL-Ela MA; Said F; Adolf S; Abdel-Razek AR; Magdy RI; Abdel-Salam A
Ann Hematol; 2014 Dec; 93(12):2045-50. PubMed ID: 25062719
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of hematological characteristics on the 79 co-inheritance of α-thalassemia and β-thalassemia carriers in Guangxi].
Xiong F; Lou JW; Wei XF; Sun MN; Huang JW; Shang X; Zhang XH; Xu XM
Zhonghua Xue Ye Xue Za Zhi; 2012 Oct; 33(10):856-60. PubMed ID: 23384911
[TBL] [Abstract][Full Text] [Related]
20. A rare example that coinheritance of a severe form of beta-thalassemia and alpha-thalassemia interact in a "synergistic" manner to balance the phenotype of classic thalassemic syndromes.
Kanavakis E; Traeger-Synodinos J; Lafioniatis S; Lazaropoulou C; Liakopoulou T; Paleologos G; Metaxotou-Mavrommati A; Stamoulakatou A; Papassotiriou I
Blood Cells Mol Dis; 2004; 32(2):319-24. PubMed ID: 15003825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
